Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts

Table of Contents

November 25, 2003; Volume 169,Issue 11

Highlights of this issue

  • You have access
    Highlights of this issue
    CMAJ November 25, 2003 169 (11) 1141;

Editorial

  • You have access
    Obituary: the Canadian Task Force on Preventive Health Care
    CMAJ November 25, 2003 169 (11) 1137;

Commentary

  • You have access
    Kava: a test case for Canada's new approach to natural health products
    Heather S. Boon and Albert H.C. Wong
    CMAJ November 25, 2003 169 (11) 1163-1164;
  • You have access
    Antiviral treatment of SARS: Can we draw any conclusions?
    Getu Zhaori
    CMAJ November 25, 2003 169 (11) 1165-1166;
  • You have access
    Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach
    Andreas Laupacis, J. Michael Paterson, Muhammad Mamdani, Alaa Rostom and Geoffrey M. Anderson
    CMAJ November 25, 2003 169 (11) 1167-1170;
  • You have access
    Why don't we initiate more large simple randomized controlled trials?
    James M. Wright
    CMAJ November 25, 2003 169 (11) 1170-1171;

News

  • You have access
    Residency crisis in offing, provinces warned
    Patrick Sullivan
    CMAJ November 25, 2003 169 (11) 1197;
  • You have access
    Drive thru, prevent flu
    Lynne Swanson
    CMAJ November 25, 2003 169 (11) 1197-1197-a;
  • You have access
    MD shortage may reignite US recruiting in Canada
    Milan Korcok
    CMAJ November 25, 2003 169 (11) 1198;
  • You have access
    Israel assumes unwanted role as world leader in disaster management
    Ann Silversides
    CMAJ November 25, 2003 169 (11) 1198-1198-a;
  • You have access
    Lack of answers concerns MDs as privacy law deadline nears
    Barbara Sibbald
    CMAJ November 25, 2003 169 (11) 1200;
  • You have access
    Measles threat re-emerges
    Barbara Sibbald
    CMAJ November 25, 2003 169 (11) 1200-1200-a;
  • You have access
    Should drug companies be allowed to sponsor Cochrane reviews?
    Ray Moynihan
    CMAJ November 25, 2003 169 (11) 1201;
  • You have access
    Bupropion: 1 drug, 4 different brand names
    Allison Gandey
    CMAJ November 25, 2003 169 (11) 1202;
  • You have access
    Preventive health care task force on brink?
    Allison Gandey
    CMAJ November 25, 2003 169 (11) 1202-1202-a;
  • You have access
    RSI placing a strain on workplace
    Tara S. Chauhan
    CMAJ November 25, 2003 169 (11) 1203;
  • You have access
    News @ a glance
    Barbara Sibbald
    CMAJ November 25, 2003 169 (11) 1204;

Research

  • You have access
    The use of cholesterol-lowering medications after coronary revascularization
    James M. Brophy, Chantal Bourgault and Paul Brassard
    CMAJ November 25, 2003 169 (11) 1153-1157;
  • You have access
    Sale of kava extract in some health food stores
    Edward Mills, Rana Singh, Cory Ross, Edzard Ernst and Joel G. Ray
    CMAJ November 25, 2003 169 (11) 1158-1159;

Review

  • You have access
    Rehabilitation medicine: 3. Management of adult spasticity
    Lalith E. Satkunam
    CMAJ November 25, 2003 169 (11) 1173-1179;

Practice

  • You have access
    Fetal alcohol spectrum disorder
    Gideon Koren, Irena Nulman, Albert E. Chudley and Christine Loocke
    CMAJ November 25, 2003 169 (11) 1181-1185;
  • You have access
    Seasonal drinking: Let's avoid the “January effect”
    Erica Weir
    CMAJ November 25, 2003 169 (11) 1186;
  • You have access
    Nefazodone (Serzone) withdrawn because of hepatotoxicity
    Stephen Choi
    CMAJ November 25, 2003 169 (11) 1187;
  • You have access
    Does the choice of β-blocker affect outcome in chronic heart failure?
    Sharon K. Bal
    CMAJ November 25, 2003 169 (11) 1188;
  • You have access
    The mystery of the broken bones
    Seyon Sathiaseelan and Umesh Rayar
    CMAJ November 25, 2003 169 (11) 1189-1190;

Letters

  • You have access
    Armoured brain
    Susan Bennett, Amy Plint and Michael Vassilyadi
    CMAJ November 25, 2003 169 (11) 1145;
  • You have access
    Armoured brain
    Neville Russell, Mohammed Al Wohaibi and Ahmad Al Ferayan
    CMAJ November 25, 2003 169 (11) 1145-1145-a;
  • You have access
    Pilot study of the Defining Issues Test
    William P. Fleisher, Cheryl Kristjanson, Gisele Bourgeois-Law and Bryan Magwood
    CMAJ November 25, 2003 169 (11) 1145-1146;
  • You have access
    MCC evaluating examination and the international medical graduate
    S. Nizam Ahmed
    CMAJ November 25, 2003 169 (11) 1146;
  • You have access
    MCC evaluating examination and the international medical graduate
    W.D. Dauphinee
    CMAJ November 25, 2003 169 (11) 1146-1147;
  • You have access
    A university's name
    June Harris
    CMAJ November 25, 2003 169 (11) 1147;
  • You have access
    SARS in health care workers
    Gordon Farrow
    CMAJ November 25, 2003 169 (11) 1147-1147-a;
  • You have access
    SARS in health care workers
    Monica Avendano, Peter Derkach and Susan Swan
    CMAJ November 25, 2003 169 (11) 1147-1147-b;
  • You have access
    Ziprasidone — not an option for serotonin syndrome
    Marshall E. Cates
    CMAJ November 25, 2003 169 (11) 1147-1148;
  • You have access
    Anaphylaxis treatment: the details
    Axel Ellrodt
    CMAJ November 25, 2003 169 (11) 1148;
  • You have access
    Anaphylaxis treatment: the details
    Patrick J. Potter
    CMAJ November 25, 2003 169 (11) 1148-1148-a;
  • You have access
    Anaphylaxis treatment: the details
    Anne K. Ellis and James H. Day
    CMAJ November 25, 2003 169 (11) 1148-1149;
  • You have access
    Corrections
    CMAJ November 25, 2003 169 (11) 1149;
  • You have access
    Corrections
    CMAJ November 25, 2003 169 (11) 1149-1149-a;

The Left Atrium

  • You have access
    Scandalous lessons
    Richard L. Cruess and Sylvia R. Cruess
    CMAJ November 25, 2003 169 (11) 1192;
  • You have access
    Sonya bright-eyes:
    Linda Clarke
    CMAJ November 25, 2003 169 (11) 1193;
  • You have access
    Hygiene
    CMAJ November 25, 2003 169 (11) 1193-1193-a;
  • You have access
    In the silent hours: the cancer paintings of Kelly Clark
    Janice Mulder and Janet Clark
    CMAJ November 25, 2003 169 (11) 1194-1195;

Deaths

  • You have access
    Deaths
    CMAJ November 25, 2003 169 (11) 1252;

Éditorial

  • You have access
    Avis de décès : le Groupe d'étude canadien sur les soins de santé préventifs
    CMAJ November 25, 2003 169 (11) 1139;

practice

  • You have access
    Drug information reference, 5th ed.
    Jim Owen
    CMAJ November 25, 2003 169 (11) 1191;
  • You have access
    Epidemiology for the uninitiated, 5th ed.
    AM Clarfield
    CMAJ November 25, 2003 169 (11) 1191-1191-a;
  • You have access
    Books received
    CMAJ November 25, 2003 169 (11) 1191-1191-b;
Back to top
PreviousNext

In this issue

Canadian Medical Association Journal: 169 (11)
CMAJ
Vol. 169, Issue 11
25 Nov 2003
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Highlights of this issue
  • Editorial
  • Commentary
  • News
  • Research
  • Review
  • Practice
  • Letters
  • The Left Atrium
  • Deaths
  • Éditorial
  • practice
  • Most Read
  • Most Cited
  • Responses
Loading
  • The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023
  • Diagnosis and management of toxicity associated with the recreational use of nitrous oxide
  • Lead toxicity from Ayurvedic medicines
  • Obesity in adults: a clinical practice guideline
  • Pelvic organ prolapse
More...

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire